Biomarker for diagnosing pulmonary edema and use thereof

摘要

It provides a composition for diagnosing pulmonary edema, a kit, and a method for providing diagnostic information, comprising an agent for measuring the expression level of a gene selected from the group consisting of CPT2 and ADRA1A or a protein encoded by the gene or the expression level of a protein thereof It is possible to objectively, simply, and accurately diagnose the risk group for pulmonary edema after administration of Drin with high accuracy and specificity.